Clinical Trials Directory

Trials / Conditions / Recurrent Pericarditis

Recurrent Pericarditis

10 registered clinical trials studyying Recurrent Pericarditis — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingTransition to KPL-387 Monotherapy Dosing & Administration Study
NCT07288216
Kiniksa Pharmaceuticals International, plcPhase 2
SuspendedEfficacy and Safety of RPH-104 Treatment in Patients With Recurrent Pericarditis
NCT05107934
R-Pharm Overseas, Inc.Phase 2 / Phase 3
RecruitingPhase 2/3 Study of KPL-387 in Recurrent Pericarditis
NCT07010159
Kiniksa Pharmaceuticals International, plcPhase 2 / Phase 3
RecruitingCardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
NCT06708299
Cardiol Therapeutics Inc.Phase 3
RecruitingAn Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis
NCT06836232
Zomagen Biosciences Ltd.Phase 2
CompletedImpact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)
NCT05494788
Cardiol Therapeutics Inc.Phase 2
Active Not RecruitingREgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients
NCT04687358
Kiniksa Pharmaceuticals International, plc—
CompletedStudy to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis
NCT03737110
Kiniksa Pharmaceuticals (UK), Ltd.Phase 3
CompletedA Pilot Study of KPL-914 in Recurrent Pericarditis
NCT03980522
Kiniksa Pharmaceuticals (UK), Ltd.Phase 2
RecruitingTherapy Management in Patients Treated With Anakinra Due to Recurrent Pericarditis
NCT06071156
Azienda Ospedaliero, Universitaria Ospedali RiunitiN/A